Back to Search
Start Over
The extreme C-terminal region of kindlin-2 is critical to its regulation of integrin activation.
- Source :
-
The Journal of biological chemistry [J Biol Chem] 2017 Aug 25; Vol. 292 (34), pp. 14258-14269. Date of Electronic Publication: 2017 Jun 26. - Publication Year :
- 2017
-
Abstract
- Kindlin-2 (K2), a 4.1R-ezrin-radixin-moesin (FERM) domain adaptor protein, mediates numerous cellular responses, including integrin activation. The C-terminal 15-amino acid sequence of K2 is remarkably conserved across species but is absent in canonical FERM proteins, including talin. In CHO cells expressing integrin αIIbβ3, co-expression of K2 with talin head domain resulted in robust integrin activation, but this co-activation was lost after deletion of as few as seven amino acids from the K2 C terminus. This dependence on the C terminus was also observed in activation of endogenous αIIbβ3 in human erythroleukemia (HEL) cells and β1 integrin activation in macrophage-like RAW264.1 cells. Kindlin-1 (K1) exhibited a similar dependence on its C terminus for integrin activation. Expression of the K2 C terminus as an extension of membrane-anchored P-selectin glycoprotein ligand-1 (PSGL-1) inhibited integrin-dependent cell spreading. Deletion of the K2 C terminus did not affect its binding to the integrin β3 cytoplasmic tail, but combined biochemical and NMR analyses indicated that it can insert into the F2 subdomain. We suggest that this insertion determines the topology of the K2 FERM domain, and its deletion may affect the positioning of the membrane-binding functions of the F2 subdomain and the integrin-binding properties of its F3 subdomain. Free C-terminal peptide can still bind to K2 and displace the endogenous K2 C terminus but may not restore the conformation needed for integrin co-activation. Our findings indicate that the extreme C terminus of K2 is essential for integrin co-activation and highlight the importance of an atypical architecture of the K2 FERM domain in regulating integrin activation.<br /> (© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Subjects :
- Amino Acid Substitution
Animals
CHO Cells
Cell Line, Tumor
Cricetulus
Gene Deletion
Humans
Integrin alpha2 chemistry
Integrin alpha2 genetics
Integrin beta3 chemistry
Integrin beta3 genetics
Leukemia, Erythroblastic, Acute pathology
Luminescent Proteins genetics
Luminescent Proteins metabolism
Macrophages cytology
Membrane Proteins chemistry
Membrane Proteins genetics
Mice
Mutation
Neoplasm Proteins agonists
Neoplasm Proteins chemistry
Neoplasm Proteins genetics
Peptide Fragments chemistry
Peptide Fragments genetics
Peptide Fragments metabolism
Protein Interaction Domains and Motifs
Protein Multimerization
RAW 264.7 Cells
Recombinant Fusion Proteins chemistry
Recombinant Fusion Proteins metabolism
Recombinant Proteins chemistry
Recombinant Proteins metabolism
Talin chemistry
Talin genetics
Talin metabolism
Integrin alpha2 metabolism
Integrin beta3 metabolism
Leukemia, Erythroblastic, Acute metabolism
Macrophages metabolism
Membrane Proteins metabolism
Neoplasm Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1083-351X
- Volume :
- 292
- Issue :
- 34
- Database :
- MEDLINE
- Journal :
- The Journal of biological chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 28652408
- Full Text :
- https://doi.org/10.1074/jbc.M117.776195